{
  "ptid_time": "137_S_4631_2012-04-30",
  "img_path": "/data/qiuhui/data/adni/images/137_S_4631/2012-04-30/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 28,413 mm³, 5.4% below the reference mean. With a Z-score of -0.13 (44.9th percentile), this represents normal volume ; hippocampal volume measures 8,271 mm³, 3.0% above the reference mean. With a Z-score of 0.30 (61.9th percentile), this represents normal volume ; whole brain volume measures 1,183,310 mm³, 4.3% above the reference mean. With a Z-score of 0.61 (72.9th percentile), this represents normal volume ; entorhinal cortex volume measures 3,686 mm³, 13.5% below the reference mean. With a Z-score of -0.94 (17.4th percentile), this represents normal volume ; fusiform gyrus volume measures 20,519 mm³, 3.1% above the reference mean. With a Z-score of 0.25 (60.1th percentile), this represents normal volume ; middle temporal gyrus volume measures 23,983 mm³, 7.0% above the reference mean. With a Z-score of 0.58 (71.8th percentile), this represents normal volume . ",
  "text_data": "Age is 69.5 years. Gender is Male. Education: 20 years. MMSE: 28.0. MoCA: 26.0. Logical Memory: 6.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.45 SUVR (significant elevated); Amyloid beta: 725.40 pg/mL (normal ); Total tau: 282.40 pg/mL (normal ); Phosphorylated tau: 30.41 pg/mL (mild elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The brain volumes are largely within normal ranges, with only the entorhinal cortex showing mild reduction (Z-score -0.94, 17.4th percentile). Cognitive scores (MMSE 28, MoCA 26) are normal, and biomarkers show normal Aβ but elevated AV45 (amyloid PET) and mildly elevated P-tau, suggesting early amyloid deposition without significant neurodegeneration.  \n**Diagnosis:** **MCI (Mild Cognitive Impairment)**  \n**Confidence:** **Medium** (Biomarkers suggest amyloid pathology, but cognitive performance remains intact, aligning with preclinical or very early MCI. The entorhinal cortex reduction is concerning but not yet severe enough for dementia.)  \n\n*Note: Given the elevated AV45 and P-tau, this individual may be in the Alzheimer’s continuum (asymptomatic or early MCI stage), but clinical symptoms do not yet meet dementia criteria. Follow-up monitoring is recommended.*",
  "timestamp": "2025-07-26T16:38:54.603733"
}